Klotho Neurosciences Ownership | Who Owns Klotho Neurosciences?


OverviewChart

Klotho Neurosciences Ownership Summary


Klotho Neurosciences is owned by 4.98% institutional investors, 13.09% insiders, and 81.93% retail investors. Meteora capital is the largest institutional shareholder, holding 9.04% of KLTO shares.

KLTO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockKlotho Neurosciences4.98%13.09%81.93%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Meteora capital5.37M9.04%$1.77M
Ubs group1.07M1.81%$354.09K
Geode capital management740.46K1.25%$244.35K
Vanguard fiduciary trust371.70K0.63%$122.66K
Brummer multi-strategy ab370.05K0.62%$122.12K
Two sigma securities203.21K0.34%$67.06K
Am investment strategies200.00K0.34%$66.00K
State street196.40K0.33%$64.81K
Blackrock funding, inc. /de143.46K0.24%$47.34K
Xtx topco136.77K0.23%$45.13K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Brummer multi-strategy ab370.05K0.51%$122.12K
Meteora capital5.37M0.13%$1.77M
Shengqi capital (hong kong)100.000.08%$33.00
Am investment strategies200.00K0.01%$66.00K
Two sigma securities203.21K0.01%$67.06K
Castleview partners10.00K0.00%$3.30K
Hickory point bank & trust5.00K0.00%$1.65K
Xtx topco136.77K0.00%$45.13K
Gabelli & co investment advisers10.00K0.00%$3.30K
Scotia capital77.05K0.00%$25.43K

Top Buyers

HolderShares% AssetsChange
Meteora capital5.37M0.13%5.37M
Ubs group1.07M0.00%556.38K
Vanguard fiduciary trust371.70K-371.70K
Geode capital management740.46K-248.63K
Two sigma securities203.21K0.01%203.21K

Top Sellers

HolderShares% AssetsChange
Citadel advisors---516.66K
Renaissance---434.57K
Brummer multi-strategy ab370.05K0.51%-236.71K
Jane street group---219.98K
Two sigma investments, lp---105.55K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust371.70K-371.70K$122.66K
Two sigma securities203.21K0.01%203.21K$67.06K
Am investment strategies200.00K0.01%200.00K$66.00K
Scotia capital77.05K0.00%77.05K$25.43K
Harbour investments23.00K0.00%23.00K$7.59K

Sold Out

HolderChange
Tower research capital llc (trc)-8.02K
Susquehanna group, llp-13.16K
Beaumont capital management-16.26K
Virtu financial-66.69K
Two sigma investments, lp-105.55K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202617-32.00%2,960,081-33.38%48.91%9-43.75%3-
Dec 31, 20252531.58%4,442,935146.89%781.51%1614.29%3-
Sep 30, 2025195.56%1,799,590104.48%345.08%14-6.67%350.00%
Jun 30, 20251880.00%880,0734.12%227.49%15275.00%2-33.33%
Mar 31, 20251011.11%845,244-15.91%311.26%4-20.00%3200.00%

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4--
2025 Q3--

KLTO Ownership FAQ


Who Owns Klotho Neurosciences?

Klotho Neurosciences shareholders are primarily institutional investors at 4.98%, followed by 13.09% insiders and 81.93% retail investors. The average institutional ownership in Klotho Neurosciences's industry, Biotech Stocks , is 35.75%, which Klotho Neurosciences falls below.

Who owns the most shares of Klotho Neurosciences?

Klotho Neurosciences’s largest shareholders are Meteora capital (5.37M shares, 9.04%), Ubs group (1.07M shares, 1.81%), and Geode capital management (740.46K shares, 1.25%). Together, they hold 12.10% of Klotho Neurosciences’s total shares outstanding.

Does Blackrock own Klotho Neurosciences?

BlackRock is not among the top 10 institutional shareholders of Klotho Neurosciences.

Who is Klotho Neurosciences’s biggest shareholder by percentage of total assets invested?

Brummer multi-strategy ab is Klotho Neurosciences’s biggest shareholder by percentage of total assets invested, with 0.51% of its assets in 370.05K Klotho Neurosciences shares, valued at 122.12K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools